IN RESPONSE:
We appreciate Dr. Grebely and colleagues' comments because they provide the opportunity for several clarifications related to our opinion advocating for HCV treatment for drug users. We wrote our article to underscore the point that persons with a history of injection and other drug use can be successfully treated for HCV infection. Although active injection drug use may not pose an absolute contraindication to HCV therapy, we believe that successful treatment of a substance use disorder helps to ensure optimal outcomes for the treatment of other relevant comorbidities, including HCV infection. We also maintain that engagement of injection ...
Reference
- 1.
Treloar C ,Rance J ,Backmund M . Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clin Infect Dis. 2013;57 Suppl 2:S51-5. [PMID:23884066 ] doi:10.1093/cid/cit263 CrossrefMedlineGoogle Scholar
Author, Article and Disclosure Information
From Eleanor Slater Hospital, Cranston, Rhode Island, and Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services, Washington, DC.
Disclosures: Authors disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-0007.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
*All comments submitted after October 1, 2021 and selected for publication will be published online only.